Diabetes affects one out of every 20 people on Earth. That equates to almost 347 million people, which is greater than the population of every country in the world except China and India. This infographic from Irish clinic Union Quay Medical Centre gives a well-informed overview of the key points relating to diabetes and tips on how to tackle Type 2 diabetes.

For a patient with an A1c of 5.7% who has been on metformin plus diet and exercise for the last 6 months, would you add another diabetes medication to the patient’s treatment? Follow the link to share your opinion.

Based upon a meta-analysis of cardiovascular outcomes in type 2 diabetes studies, findings suggest that a 15% relative risk reduction in nonfatal myocardial infarcts is associated with an A1C reduction of approximately: a) .50% b) 1.0% c) 1.5% d) 2.0% Did you get it right? Follow the link to find out!

Guest Post by David Kliff, Diabetic Investor Recently we learned the identity of the new British Prime Minister, Theresa May, who, according to a post on www.jdrf.org.uk, is a type 1 diabetic. The post states: “The Home Secretary Theresa May is on course to become the first prime minister who …

The benefits of weight loss surgery for younger patients may persist for years.

Weight loss surgery helping in the reduction of type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease sexual dysfunction -- even mortality rate.

42 year old female, 5’ 4”, 275 lbs, BMI 47.2 kg/m2. History of hypertension, chronic low back pain, severe gastroesophageal reflux disease, depression and type 2 diabetes (diagnosed 2 years ago), and anxiety/depression. Medications include lisinopril 10 mg daily, oxycodone 5 mg TID prn, omeprazole 20 mg daily, metformin 500 mg BID, and paroxetine 20 mg daily. She has been actively working with her PCP on losing weight with diet modification and water aerobics but has only lost about 4% of her weight in the past 6 months. Current labs: (fasting) blood glucose 154 mg/dl, Hgb A1c 6.7 Creatinine 1.6, mg/dl and TSH of 3.6 U/ml. What is the best course of action?

African American male, 63 years of age, type 2 diabetes, hypertension, strong family history of type 2 diabetes, hypertension and stroke. A1C is 6.7%. Blood pressure 160/96 HR 88, despite being on ACE-I and Beta Blocker.

We were at the ADA and AACE and have over 45 video interviews with some great information. Would you prefer to watch a video interview in its entirety, or an interview broken up into Q&A segments? Follow the link and let us know your opinion!

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.